Flores Jackeline, Pena Camilo, Nugent Kenneth
Texas Tech University Health Sciences Center, School of Medicine, Department of Internal Medicine, Lubbock, Texas, United States.
J Bras Nefrol. 2025 Jul-Sep;47(3):e202440192. doi: 10.1590/2175-8239-JBN-2024-0192en.
Hypertension is an important risk factor for myocardial infarction, stroke, peripheral arterial disease, and chronic kidney disease. The World Health Organization has determined that approximately 1.28 billion adults worldwide have high blood pressure. Its definition has changed over the years, and in 2017 the American College of Cardiology and the American Heart Association have defined blood pressures ≥ 130/80 mmHg as hypertension.
The PubMed database was searched using the MeSH terms sodium, capillary resistance, hypertension, and microvascular rarefaction to identify articles relevant to skin sodium levels, peripheral circulations and vascular rare fraction, and hypertension.
Experimental animal and human studies indicate that there are fewer capillaries and arterioles in patients with primary hypertension, and decreased density, also known as rarefaction, increases peripheral resistance. Microvascular density can be estimated noninvasively by methods such as intravital video microscopy in cutaneous regions or in nailfolds. The mechanisms of the reduction in density have been studied and could be used as a parameter when evaluating therapeutic options for patients. The skin provides a reservoir for sodium and can help moderate fluctuations in blood pressure associated with changes in sodium intake. In addition, the skin can modulate fluid volumes in the body through transepidermal water loss.
This review discusses microvascular rarefaction, changes in microvasculature structure including the skin capillaries with hypertension, the association between sodium and skin physiology relevant to hypertension, transepidermal water loss, and the vascular effects associated with some antihypertensive medications that help explain their benefit in the prevention of cardiovascular events.
高血压是心肌梗死、中风、外周动脉疾病和慢性肾病的重要危险因素。世界卫生组织已确定,全球约有12.8亿成年人患有高血压。多年来其定义不断变化,2017年美国心脏病学会和美国心脏协会将血压≥130/80 mmHg定义为高血压。
使用医学主题词“钠”“毛细血管阻力”“高血压”和“微血管稀疏”在PubMed数据库中进行检索,以识别与皮肤钠水平、外周循环和血管稀疏分数以及高血压相关的文章。
实验动物和人体研究表明,原发性高血压患者的毛细血管和小动脉较少,密度降低,即稀疏,会增加外周阻力。微血管密度可通过诸如皮肤区域或甲襞的活体视频显微镜等方法进行无创估计。已经对密度降低的机制进行了研究,并且在评估患者的治疗选择时可将其用作一个参数。皮肤是钠的储存库,有助于调节与钠摄入量变化相关的血压波动。此外,皮肤可通过经皮水分流失调节体内液体量。
本综述讨论了微血管稀疏、包括高血压患者皮肤毛细血管在内的微血管结构变化、与高血压相关的钠和皮肤生理学之间的关联、经皮水分流失以及一些抗高血压药物的血管效应,这些有助于解释它们在预防心血管事件中的益处。